The medical representative Q3 is difficult.

TextAnia Pharmaceutical symbes Are facing a more serious situation because of the inventory, high indicators, some products off-season, the third batch of volume procurement and other factorsQ3 more severe in recent days, a lot of layoffs, optimization, compliance, fly inspection news came, giving birth to people's nervous moodfor many pharmaceutical representatives, by the end of the quarter, the next quarter immediately began, with new indicators and resources, looking for new growth points has become their Q3 main considerationto this, senior medical representative Luo Wet brother has written that: for many representatives, Q3 probability is not so optimistic, July is a watershed, decided a lot of representatives of the rice bowl is able to live, whether the product can still do, there is no opportunity for promotionhe believes that many pharmaceutical companies in July will be the last phase-out results, there is a danger of generally is the sales contribution is not large, or responsible for product import sourcing of pharmaceutical representativesthe situation faced by the pharmaceutical representative Q3 is indeed more serious, because of the inventory, high indicators, some products off-season, the third batch of volume procurement and other factorsChongqing Doptai Pharmaceutical Promotion Minister Zhao Jiazhen told Seiber Blue, from the sales situation, the general traditional off-season is in the third quarter, the third quarter should be the four quarters of the lowest sales of the month;he admitted that many pharmaceutical companies may not have anticipated that the impact of the outbreak will last so long, especially for some companies doing outpatient medication, such as chronic disease drugs, otolaryngology drugsthe essence of pharmaceutical representatives is the sales attribute, so the performance appraisal at different stages focuses on differentZhao Jiazhen to The Seibrand explanation: the representative of the assessment items have two types, one is sales management, one is process management, such as the frequency of his visits, the number of visits, the number of people, etc;generally speaking, Q1 will focus on the development of hospitals and the number of new doctors, Q2, Q3 will focus on doing some on-the-top work, mainly in process management to visit frequency and frequency requirements, to Q4 will do sales indicators for the whole year reached sprint, as well as inventory digestiontherefore, the core work of the pharmaceutical representative Q3 lies in the focus of the target VIP maintenance work, it is worth noting that many pharmaceutical companies are difficult to carry out offline learning activities, you can try to start online academic conferences, to assist the relevant market departments to start expert maintenance workZhao Jiazhen suggestedthe third batch of collection and filing system, affecting a large number of pharmaceutical representatives now, the country's provinces began to the third batch of national collection of the amount of protection, a total of 86 product regulations, involving a total of 300 pharmaceutical enterprisesAccording to an online meeting of the relevant countries in the industry, the local survey volume and balance retention policy training, by July 3 to complete the reportcombined with the pace of two batches of the previous year's rotation, the third round of national procurement of quotations is likely to start around the end of Julyin addition, on June 5, the industry's high-profile "Measures for the Record Management of Pharmaceutical Representatives (Trial)" (draft for comments) (hereinafter referred to as the "Draft for Comments") again open for commentsthe Measures for the Administration of Filing, medical representatives may carry out academic promotion and other activities in the following forms: (1) communicating with medical personnel in person with medical institutions; (2) holding academic conferences and lectures; (3) providing academic materials; (4) communicating via the Internet or teleconference; and (5) other forms agreed by medical institutionsto some extent, the management and regulation of medical representatives has been put on the national agendaZhao Jiazhen believes that: the above two on the pharmaceutical representatives of the impact is very large, on the one hand, the pharmaceutical representative filing system will be issued details of the next document;he further explained that the most important direction of the former medical representatives is the customer ship, the future of the core direction of the pharmaceutical representatives, must be to the guest and academic direction to transformfor example, how to give large VIP, expert network empowerment? How to use online and offline methods to get your doctor to digest your promotional focus..Whether it's marketing or clinical teams, this is a common problem for the future" overall, I think the pressure on future medical representatives is very great, because they have to follow the direction of the national health reform policy to transform, not only rely on the customer-and-gold way to promote products, but through the real compliance of academic promotion, as well as online and online three-dimensional academic conferences and activities to promote their products," Zhao Jiazhen said.